Is it Time to Take Profits in Inovalon Holdings (INOV)?

Bernzott Capital Advisors, an investment management firm, published its “US Small Cap Value Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here. The portfolio rose 4.2% (gross) slightly underperforming the Russell 2000 Value’s advance of 4.3%, and somewhat less than the Russell 2500 Value’s gain of 6.3%. Industrials, the sector with the largest allocation at 35.2% of the portfolio, was the largest positive contributor to returns led by capital goods holdings. Spare some time to check the fund’s top 5 holdings to have a clue about their top bets for 2022.

Bernzott Capital Advisors US Small Cap Value, in its Q4 2021 investor letter, mentioned Inovalon Holdings, Inc. (Former NASDAQ: INOV) and discussed its stance on the firm. Inovalon Holdings, Inc. is a Bowie, Maryland-based healthcare technology company with a $791.0 million market capitalization. INOV delivered a 5.19% return since the beginning of the year, while its 12-month returns are up by 101.42%. The stock closed at $3.76 per share on February 4, 2022.

Here is what Bernzott Capital Advisors US Small Cap Value has to say about Inovalon Holdings, Inc. in its Q4 2021 investor letter:

“Inovalon (INOV): This cloud-based healthcare data analytics provider agreed in August to be acquired by a group of private equity investors for $42.00 in cash, a 25% premium to trading levels prior to announcement. We exited this two-and-a-half year holding more than three times higher than our initial purchase price.”

Romaset/Shutterstock.com

Our calculations show that Inovio Pharmaceuticals, Inc. (NASDAQ: INOV) failed to obtain a mark on our list of the 30 Most Popular Stocks Among Hedge Funds. INOV was in 27 hedge fund portfolios at the end of the third quarter of 2021, compared to 2 funds in the previous quarter. Inovio Pharmaceuticals, Inc. (NASDAQ: INOV) delivered a 42.00% return in the past 3 months.

In November 2021, we also shared another hedge fund’s views on INOV in another article. You can find other letters from hedge funds and prominent investors on our hedge fund investor letters 2021 Q4 page.

Disclosure: None. This article is originally published at Insider Monkey.